Familial hypertrophic cardiomyopathy
MONDO:0024573Hypertrophic cardiomyopathy caused by mutations in the genes encoding components of the sarcomere, in the absence of predisposing conditions.
Also known as: cardiomyopathy, familial hypertrophic, familial hypertrophic cardiomyopathy, familila or idiopathic hypertrophic obstructive cardiomyopathy, hereditary hypertrophic cardiomyopathy, hypertrophic familial cardiomyopathy
94 clinical trials for this condition and its sub-types, 2 tagged with Familial hypertrophic cardiomyopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Familial hypertrophic cardiomyopathy
-
Myotonic dystrophy type 1 45 trials
1 sub-type
-
Noonan syndrome and Noonan-related syndrome 1 trial · 29 incl. sub-types
6 sub-types
- Noonan syndrome 22 trials · 25 incl. sub-types Sub-types →
- Costello syndrome 7 trials
- Cardiofaciocutaneous syndrome 7 trials Sub-types →
- Legius syndrome 5 trials
- Noonan syndrome with multiple lentigines 3 trials Sub-types →
- Noonan syndrome-like disorder with loose anagen hair 0 trials Sub-types →
-
Beckwith-Wiedemann syndrome 6 trials
8 sub-types
- Beckwith-Wiedemann syndrome due to 11p15 microdeletion 0 trials
- Beckwith-Wiedemann syndrome due to 11p15 microduplication 0 trials
- Beckwith-Wiedemann syndrome due to 11p15 translocation/inversion 0 trials
- Beckwith-Wiedemann syndrome due to CDKN1C mutation 0 trials
- Beckwith-Wiedemann syndrome due to NSD1 mutation 0 trials
- Beckwith-Wiedemann syndrome due to imprinting defect of 11p15 0 trials
- Beckwith-Wiedemann syndrome due to paternal uniparental disomy of chromosome 11 0 trials
- Franceschini Vardeu Guala syndrome 0 trials
-
Dilated cardiomyopathy 1C 1 trial
-
5 sub-types
- Glutaric acidemia IIa 0 trials
- Glutaric acidemia IIb 0 trials
- Glutaric acidemia IIc 0 trials
- Multiple acyl-CoA dehydrogenase deficiency, mild type 0 trials
- Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type 0 trials
-
46,XY complete gonadal dysgenesis 0 trials · 1 incl. sub-types
12 sub-types
- 46,XY sex reversal 5 1 trial
- 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency 0 trials
- 46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome 0 trials
- 46,XY sex reversal 1 0 trials
- 46,XY sex reversal 10 0 trials
- 46,XY sex reversal 11 0 trials
- 46,XY sex reversal 2 0 trials
- 46,XY sex reversal 3 0 trials
- 46,XY sex reversal 4 0 trials
- 46,XY sex reversal 6 0 trials
- 46,XY sex reversal 7 0 trials
- 46,XY sex reversal 9 0 trials
-
Dilated cardiomyopathy 1KK 0 trials
-
Hypertrophic cardiomyopathy 1 0 trials
-
Hypertrophic cardiomyopathy 10 0 trials
-
Hypertrophic cardiomyopathy 11 0 trials
-
Hypertrophic cardiomyopathy 12 0 trials
-
Hypertrophic cardiomyopathy 13 0 trials
-
Hypertrophic cardiomyopathy 14 0 trials
-
Hypertrophic cardiomyopathy 15 0 trials
-
Hypertrophic cardiomyopathy 16 0 trials
-
Hypertrophic cardiomyopathy 17 0 trials
-
Hypertrophic cardiomyopathy 18 0 trials
-
Hypertrophic cardiomyopathy 19 0 trials
-
Hypertrophic cardiomyopathy 2 0 trials
-
Hypertrophic cardiomyopathy 20 0 trials
-
Hypertrophic cardiomyopathy 21 0 trials
-
Hypertrophic cardiomyopathy 25 0 trials
-
Hypertrophic cardiomyopathy 26 0 trials
-
Hypertrophic cardiomyopathy 3 0 trials
-
Hypertrophic cardiomyopathy 4 0 trials
-
Hypertrophic cardiomyopathy 6 0 trials
-
Hypertrophic cardiomyopathy 7 0 trials
-
Hypertrophic cardiomyopathy 8 0 trials
-
Hypertrophic cardiomyopathy 9 0 trials
Most studied deeper sub-types
-
New cancer pill shows early promise, but trial halted
Disease control Stopped earlyThis early-stage trial tested an oral drug called TNO155, alone or with another drug (nazartinib), in 227 adults with advanced solid tumors like lung cancer, melanoma, and head/neck cancer. The main goal was to check safety and find the right dose. The study was terminated early,…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Scientists dive into cells to unravel costello Syndrome's secrets
Knowledge-focused Stopped earlyThis study collects small skin samples from children aged 2 to 17 with Costello syndrome or a related condition. Researchers will analyze the cells to understand how a mutation in the HRAS gene affects energy use and mitochondria. The goal is to learn more about the disease's und…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC